|
Edward
Snyder , MD
Professor
of Laboratory Medicine/Associate
Chair for Clinical Affairs
Director, Apheresis/Transfusion
Service
Director, Blood
Bank
Director, Transfusion
Medicine Fellowship
Editor, Lab
News
Office: CB-459
Phone: 203-688-2441
Fax: 203-688-2748
Email: edward.snyder@yale.edu
B.A.,
1967, Harpur College State University of New York at Binghamton
M.A., 1969, Harpur College State University of New York at Binghamton
M.D., 1973, New York Medical College
Fellowship: Hematology/Transfusion Medicine, Montefiore Hospital
Community
of Science Biosketch
Research
Interests
Dr. Snyder's research relates to the broad field
of Transfusion Medicine and, more specifically, Transfusion Oncology
and Transfusion Immunobiology. His current research includes an
on-going evaluation of the platelet storage lesion. This includes
evaluation of alterations that occur in platelet metabolism during
various storage conditions, in the platelet's cystoskeleton and
in the mitochondria within platelets. Studies of the in vitro and
in vivo aspects of platelet storage are an on-going effort in the
laboratory. Dr. Snyder also has a long-term history of investigating
the role of leukodepletion in blood components. Most recently, the
laboratory has turned to the evaluation of new pathogen reduction
technology. This includes the addition of various compounds to blood
to remove known and potentially dangerous, as well as unknown, viral,
bacterial, and protozoal contaminants in donated blood. The laboratory
has a special expertise in radiolabeling human blood cells. The
laboratory is currently performing clinical trials related to in
vivo recovery and survivals using indium-111 and chromium-51 radiolabeled
platelets and red cells, as well as Phase III trials for transfusion
of pathogen-reduced blood components into patients. We are also
involved in ongoing evaluations of clinical responses of patients
to pheresis interventions for a variety of immunologic disorders.
This is often done in conjunction with the evaluation of new apheresis
machine hardware developed by a variety of corporations.
Clinical
and Teaching Activities
Dr.
Snyder is Board Certified in Internal Medicine, Hematology, and
Transfusion Medicine. His clinical work is aimed at transfusion
practice and primarily encompasses classical transfusion medicine,
as well as the clinical apheresis service where he is responsible
for the oversight of the plasmapheresis, leukapheresis, and plateletpheresis
services. We are also involved in the collection and processing
of peripheral blood stem cells for the Yale Stem Cell Transplant
Program and in the collection of mononuclear cells for donor lymphocyte
infusion. Dr. Snyder is the medical director of the Frisbee Laboratory,
a Class 10,000 facility for the preparation of cellular therapy
products. Dr. Snyder participates in the Department of Laboratory
Medicine's T-32 NIH grant for training in immunohematology and transfusion
medicine. To E-mail Dr. Snyder, please click
here.
Publications
Snyder EL, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin J-S, Corash L and Conlan MG for the SPRINT Study Group. Clinical Safety of Platelets Photochemically Treated with Amotosalen HCl and Ultraviolet A Light for Pathogen Inactivation: The SPRINT Trial. Transfusion 2005;45:1864-75.
AuBuchon JP, Snyder EL.The rationale for a standardized approach to assessment of platelet kinetics. Transfusion 2006;46:(in press).
Slichter SJ, Baril L, Corda T, Dincecco D, Bolgiano D, MK Jones, Christoffel T, Corson J, Snyder EL. Viability and function of 8-day stored Haemonetics& apheresis platelets. Transfusion 2006;46:(in press).
Snyder
EL, O'Donnell L, Dengler TJ, Pomper GJ, Velleca MA, Dincecco DM,
Baril LL, Min K, Gudino MD, Bender JR. Ex vivo evaluation of PBMNCs
collected with a new cell separator. Transfusion 41:940-949, 2001.
Debalak
J, Shlomchik MJ, Snyder EL,Krause DS. Isolation of T cell
depleted CD34+ peripheral blood stem cells using the Isolex 300I
magnetic cell separator. Bone Marrow Transplantation, in press,
2001.
Snyder
EL, et al. In vitro collection and post-transfusion engraftment
of MNCs obtained by using a new separator for autologous PBPC
transplantation. Transfusion 40:961-967, 2000.
McQuiston
JH,Snyder EL, Chamberland ME. Transmission of tickborne
agents by blood transfusion. Transfusion 40:274-284, 2000.
Burtness
BA, Psyrri A, Rose M, Snyder EL,Cooper D. A phase
I study of pacitaxel for mobiliation of peripheral blood progenitor
cells. Bone marrow Transplantation 23:311-315, 1999.
Snyder
EL, Perrotta P, Rinder H, Baril L, Nichol J. Effects of PEG-rHu
megakaryocyte growth and development factor on the platelet storage
lesion. Transfusion 39:258-264, 1999.
Perrotta
PL, Baril, L, Tead C, Chapman J, Buchholz D, Snyder EL. Effects
of methylene blue-treated plasma on red cells and stored platelet
concentrates. Transfusion 39:63-69, 1999.
Klein
HG, Dodd RY, Dzik WH, Luban NL, Ness P, Pisciotto P. Schiff P,
Snyder E. Status of solvent/detergent-treated frozen plasma. Transfusion
38:102-107, 1998.
Geiger
TL, Perrotta P, Davenport R, Baril L, Snyder EL. Removal of C3a
and C5a and chemokines IL-8, RANTES by leukoreduction and plasma
filters. Transfusion 37:1156-1162, 1997.
Snyder
EL, Mechanic S, Baril L, Davenport R. Removal of soluble BRMs
(complement and chemokines) by a bedside leukoreduction filter.
Transfusion 36:707-713, 1996.
Blundell
EL, Pamphilon D, Fraser I, Kagen L, Menitove J, Aster R, Greenwalt
T, Snyder EL, et al. A prospective randomized study of platelet
concentrates irradiated with UV-B light in patients with haematological
malignancy. Transfusion 36:296-302, 1996.
Stack
G, Baril L, Napychank P, Snyder EL. Cytokine generation in stored
white cell reduced and bacterially contaminated units of red cells.
Transfusion 35:199-203, 1995.
Geiger
T, Pisciotto P, Baril L, Snyder EL. The effect of solvent detergent
treated plasma on stored red cells in vitro. Transfusion 35:487-492,
1995.
Stack
G, Snyder EL. Cytokine generates in stored platelet concentrates.
Transfusion 34:20-25, 1994.
Buchholz
DH, AuBuchon JP, Snyder EL, et al. Effects of white cell reduction
on the resistance of blood components to bacterial multiplication.
Transfusion 34:20-25, 1994.
|